Literature DB >> 18625582

Animal welfare and the refinement of neuroscience research methods--a case study of Huntington's disease models.

I Anna S Olsson1, Axel K Hansen, Peter Sandøe.   

Abstract

The use of animals in biomedical and other research presents an ethical dilemma: we do not want to lose scientific benefits, nor do we want to cause laboratory animals to suffer. Scientists often refer to the potential human benefits of animal models to justify their use. However, even if this is accepted, it still needs to be argued that the same benefits could not have been achieved with a mitigated impact on animal welfare. Reducing the adverse effects of scientific protocols ('refinement') is therefore crucial in animal-based research. It is especially important that researchers share knowledge on how to avoid causing unnecessary suffering. We have previously demonstrated that even in studies in which animal use leads to spontaneous death, scientists often fail to report measures to minimize animal distress (Olsson et al. 2007). In this paper, we present the full results of a case study examining reports, published in peer-reviewed journals between 2003 and 2004, of experiments employing animal models to study the neurodegenerative disorder Huntington's disease. In 51 references, experiments in which animals were expected to develop motor deficits so severe that they would have difficulty eating and drinking normally were conducted, yet only three references were made to housing adaptation to facilitate food and water intake. Experiments including end-stages of the disease were reported in 14 papers, yet of these only six referred to the euthanasia of moribund animals. If the reference in scientific publications reflects the actual application of refinement, researchers do not follow the 3Rs (replacement, reduction, refinement) principle. While in some cases, it is clear that less-than-optimal techniques were used, we recognize that scientists may apply refinement without referring to it; however, if they do not include such information in publications, it suggests they find it less relevant. Journal publishing policy could play an important role: first, in ensuring that referees seriously consider whether submitted studies were indeed carried out with the smallest achievable negative impact on the animals and, secondly, in encouraging scientists to share refinements through the inclusion of a 3Rs section in papers publishing the results of animal-based research.

Entities:  

Mesh:

Year:  2008        PMID: 18625582     DOI: 10.1258/la.2008.007147

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  5 in total

1.  The welfare of animals used in science: how the "Three Rs" ethic guides improvements.

Authors:  Nicole Fenwick; Gilly Griffin; Clément Gauthier
Journal:  Can Vet J       Date:  2009-05       Impact factor: 1.008

Review 2.  "What's wrong with my monkey?" Ethical perspectives on germline transgenesis in marmosets.

Authors:  I Anna S Olsson; Peter Sandøe
Journal:  Transgenic Res       Date:  2009-08-19       Impact factor: 2.788

Review 3.  Using non-invasive neuroimaging to enhance the care, well-being and experimental outcomes of laboratory non-human primates (monkeys).

Authors:  M A Basso; S Frey; K A Guerriero; B Jarraya; S Kastner; K W Koyano; D A Leopold; K Murphy; C Poirier; W Pope; A C Silva; G Tansey; L Uhrig
Journal:  Neuroimage       Date:  2020-12-24       Impact factor: 6.556

4.  In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington's Disease.

Authors:  Ji-Hea Yu; Bae-Geun Nam; Min-Gi Kim; Soonil Pyo; Jung-Hwa Seo; Sung-Rae Cho
Journal:  Genes (Basel)       Date:  2021-05-10       Impact factor: 4.096

5.  Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.

Authors:  Joana G Fernandes; Nuno H Franco; Andrew J Grierson; Jan Hultgren; Andrew J W Furley; I Anna S Olsson
Journal:  BMJ Open Sci       Date:  2019-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.